Human GREB1 peptide

This study was conducted to determine the time course of gene expression associated with specific signaling pathways in normal human bronchial epithelial (NHBE) cells after exposure to 2 concentrations of 2R4F tobacco mainstream smoke (MSS). Expression of 84 genes representing 18 signal transduction pathways was quantitated. in MSS- and air-exposed cultures using great-time polymerase chain reaction (PCR) arrays at 1, 4, and 24 hours following exposure. A confidence score, calculated based on statistical analysis of the degree and reproducibility of expression changes, was used to identify, potential biologically significant changes in gene expression. Stimulation of NIAP an apoptosis inhibitor suppression of AFKB1 and MYC, representing pro-apoptotic activity, and down-regulation of TCF7 and up-regulation of KLK2, representing anti-/pro-inflammatory responses, were altered I hour after exposure to the high concentration of MSS. At the 4-hour time point, the pattern had changed such that 10 different genes were now up-regulated and an additional gene was now down-regulated. Significant changes included genes involved in inflammatory response (LTA, SELPLG, and IL8), repair and wound-healing activity (MMP10), and growth activity (GREB1, EGR1), suggesting repair in. this period. BY 24 hours, the only up-regulated genes in common with the 4-hour Profile were SELPLG and IL8, suggesting continued inflammatory signaling. These results suggest that identification, of specific gene expression-based. biomarkers of MSS toxicity is promising for investigating specific gene expression-based biomarkers of expressed signal were dependent on the concentration of MSS and the postexposure times.

Oestrogen receptor alpha (ER alpha) is overexpressed in two-thirds of all breast cancers and involves in development and breast cancer progression. Although ER alpha-positive breast cancer could be effective treated by endocrine therapy, the endocrine resistance is still an urgent clinical problem. Thus, further understanding of the underlying mechanisms ER alpha signalling is critical in dealing with endocrine resistance in breast cancer patients. MCF-7 and T47D breast cancer cell lines are used to carry out the molecular biological experiments. Western blot is used to assess the relative protein level of ER alpha, RNF168 and actin. Real-time PCR is used the measure the relative ER alpha-related gene mRNA level. Luciferase assay is used to measure the relative ER alpha signalling activity. Chromatin immunoprecipitation is used to measure the RNF168 binding affinity to ER alpha promoter regions. WST assay and flow cytometry are used to measure the cell proliferation capacity. We use Student's t test and one-way ANOVA test for statistical data analysis. Here, we report an important role in ER alpha-positive breast cancer cells for RNF168 protein in supporting cell proliferation by driving the transcription of ER alpha. RNF168 is highly expressed in breast cancer samples, compared with normal breast tissue. In patients with breast cancer, RNF168 expression level is correlated with poor endocrine treatment outcome. Depletion of RNF168 causes decreased cell proliferation in MCF-7 and T47D cells. Besides, depletion RNF168 reduced mRNA level of ER alpha and its target genes, such as PS2 and GREB1. Chromatin immunoprecipitation revealed that ER alpha transcription is associated with RNF168 recruitment to ER alpha promoter region, suggesting that transcriptional regulation is one mechanism by which RNF168 regulates ER alpha mRNA level and ER alpha signalling in breast cancer cells. RNF168 is required for ER alpha-positive breast cancer cell proliferation and facilitate ER alpha signalling activity possibly through promoting transcription of ER alpha.